Harry’s the Bees Knees at England Bowls

Published in News

Harry Redknapp becomes the new manager of the England Bowls team after knee troubles

It’s the moment we’ve all been waiting for as Harry Redknapp made his long awaited international managerial debut today, but not necessarily in a role we would have expected.

Redknapp, who most recently managed Premier League outfit Queens Park Rangers, started the next chapter in his management career today when he was dramatically revealed as the new manager of the England Bowls team in front of startled players, spectators and media alike.

[DATE] 2015, London: Pro Bono Bio plc welcomes today the publication of an independent study into the effects of FLEXISEQ Sport versus a prescription pain killer on muscle soreness and recovery after exercise.

Published in the Journal of Sports Sciences1, the investigation shows that FLEXISEQ Sport reduces muscle soreness faster than a prescription oral painkiller (ketoprofen 100mg, twice daily), avoiding the known problem of NSAID-delayed recovery.

During the study, healthy volunteers aged 18-55 repeatedly descended stairs for 40 minutes from an altitude of up to 400m to induce muscle soreness 12 hours later. Participants with measurable muscle soreness in the calves were then randomised to a number of treatment arms including oral ketoprofen 100mg and drug-free FLEXISEQ Sport, both received twice daily for 7 days after the onset of muscle soreness.

FLEXISEQ® SPORT Launches in the UK

Published in News

Drug-free gel for a healthier active lifestyle

22nd January 2015, London: FLEXISEQ Sport launches today in the UK, for all active people (including athletes and members of the armed forces), who want to protect and care for their joints.

Drug-free FLEXISEQ Sport is screened to be free of any trace substances banned by the World Anti-Doping Agency (WADA) and comes in a hotly anticipated 100g pack-size to treat and protect multiple joints.
Regular exercise can place strain on joints and FLEXISEQ Sport allows users to stay active without the distraction of joint pain and stiffness, overuse of painkillers or worries about doping. The product has been tested in the hardest impact sports to ensure it can meet any challenge.

FLEXISEQ Sport is suitable for all active people and has been tested on and developed with professional athletes, across many sporting disciplines to manage joint pain and restore function, without the use of drugs. While the product is clinically proven to relieve the symptoms of all stages of osteoarthritis, including pain and stiffness, its use in sport has generated some remarkable examples of injury rehabilitation.

SEA Games Gold Medalist Mok Shares Top Tips to Guard Against Injuries

Clinching his 5th gold medal in Standard Chartered Marathon Singapore, the SEA Games marathon gold medalist, Mok Ying Ren, has leaped ahead on his Road to Rio 2016. His eyes are set on his next mark – SEA Games 2015, and thereafter, he is planning a more intensive training stint overseas. It is certain that Mok’s road ahead is lined with rigorous training and he is taking measures to stay as injury-free as possible throughout this crucial period.


FLEXISEQ, the drug-free, pain relieving gel used to treat sufferers of osteoarthritis (OA) and joint damage, has announced several new additions to its expanding team of brand ambassadors.

Former England prop and Rugby World Cup winning legend, Jason Leonard, joins current Northampton Saints and England international Alex Corbisiero and Welsh three time Grand Slam winner Ryan Jones, as the latest additions to the FLEXISEQ ambassador squad.

The trio of top rugby players follow Saracens and England centre, Brad Barritt, who was the first rugby player to endorse the product earlier this year.

1st May 2014, London: Pro Bono Bio (PBB), the world leader in nano-physical medical devices, is proud to announce that it has been appointed as an official supplier to top English premiership rugby club, Saracens, for their breakthrough joint-care product, FLEXISEQ®.

This announcement is the culmination of nearly 6 months of collaboration between PBB and the Saracens medical staff who have been trialling FLEXISEQ among players of their elite squad, since the product hit the UK market in early December 2013.

28th January 2014, London: Pro Bono Bio®, the global leader in nano-physical healthcare products, announces the UK national launch of FLEXISEQ™, the innovative drug-free, safe treatment for joint pain associated with osteoarthritis1 (OA) following the successful conclusion of the pioneering 2 month Charity partnership phase for the benefit of Arthritis Research UK. The contribution in products that are sold through the Arthritis Research UK website and through LloydsPharmacy has raised over £400,000 for the medical research charity. Sufferers have enthusiastically welcomed the new, effective and safe product that they can self-medicate and it is now going on sale through all leading pharmacies in the
UK.  FLEXISEQ comes with significant advantages as the product has no contra-indications, contains no drugs so cannot cause drug-to-drug interactions and so is safer than the existing drug treatments.

3rd December 2013, London: Pro Bono Bio®, the global leader in nano-physical healthcare products, announces the UK Charity launch of FLEXISEQ™, the innovative drug-free, safe treatment for joint pain associated with osteoarthritis₁ (OA). FLEXISEQ's proven efficacy comes with significant advantages as the product has no contra-indications, contains no drugs so cannot cause drug-to-drug interactions, and with over 6 million doses administered since launch there have been no reported systemic side effects.

FLEXISEQ is already successfully sold in the early pilot markets of Austria, Germany, Ireland, Malaysia and Singapore. Earlier this year, FLEXISEQ won the Innovation Award 2013 from the Federal Association of German Pharmacists. In June, FLEXISEQ launched in Ireland and became the fastest growing over-the-counter product that pharmacies there had seen in recent times.